These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 21596335)

  • 1. Usefulness of rotational atherectomy in preventing polymer damage of everolimus-eluting stent in calcified coronary artery.
    Kuriyama N; Kobayashi Y; Yamaguchi M; Shibata Y
    JACC Cardiovasc Interv; 2011 May; 4(5):588-9. PubMed ID: 21596335
    [No Abstract]   [Full Text] [Related]  

  • 2. Delamination of abluminal polymer of biolimus-eluting stent.
    Fujimoto Y; Kobayashi Y; Yamaguchi M
    JACC Cardiovasc Interv; 2012 Mar; 5(3):e5-6. PubMed ID: 22440509
    [No Abstract]   [Full Text] [Related]  

  • 3. Warning: this report does not address heavily calcified coronary arteries.
    Butman SM
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):643. PubMed ID: 20976745
    [No Abstract]   [Full Text] [Related]  

  • 4. Five-year long-term clinical follow-up of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial.
    Wiemer M; Serruys PW; Miquel-Hebert K; Neumann FJ; Piek JJ; Grube E; Haase J; Thuesen L; Hamm C
    Catheter Cardiovasc Interv; 2010 Jun; 75(7):997-1003. PubMed ID: 20517959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
    Claessen BE; Smits PC; Kereiakes DJ; Parise H; Fahy M; Kedhi E; Serruys PW; Lansky AJ; Cristea E; Sudhir K; Sood P; Simonton CA; Stone GW
    JACC Cardiovasc Interv; 2011 Nov; 4(11):1209-15. PubMed ID: 22115661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II study.
    Onuma Y; Tanimoto S; Ruygrok P; Neuzner J; Piek JJ; Seth A; Schofer JJ; Richardt G; Wiemer M; Carrié D; Thuesen L; Dorange C; Miquel-Hebert K; Veldhof S; Serruys PW
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):634-42. PubMed ID: 20690152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vivo acute stent recoil between the bioresorbable everolimus-eluting coronary scaffolds (revision 1.0 and 1.1) and the metallic everolimus-eluting stent.
    Onuma Y; Serruys PW; Gomez J; de Bruyne B; Dudek D; Thuesen L; Smits P; Chevalier B; McClean D; Koolen J; Windecker S; Whitbourn R; Meredith I; Garcia-Garcia H; Ormiston JA;
    Catheter Cardiovasc Interv; 2011 Jul; 78(1):3-12. PubMed ID: 21413120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete fracture and migration of a coronary sirolimus-eluting stent.
    Eshtehardi P; Ghassemi-Kakroodi P; Mousavi N; Garachemani A; Moayed DA
    J Cardiovasc Med (Hagerstown); 2011 Apr; 12(4):271-3. PubMed ID: 20671570
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute stent recoil from aggressive post-dilation of a second-generation drug-eluting stent.
    Takagi K; Yakushiij T; Basavarajaiah S; Chieffo A; Hasegawa T; Colombo A
    JACC Cardiovasc Interv; 2013 Mar; 6(3):311-3. PubMed ID: 23517845
    [No Abstract]   [Full Text] [Related]  

  • 10. Gender medicine and drug eluting coronary stents.
    Kornowski R
    Catheter Cardiovasc Interv; 2010 Nov; 76(6):814-6. PubMed ID: 21104730
    [No Abstract]   [Full Text] [Related]  

  • 11. Randomized comparison of a polymer-free sirolimus-eluting stent versus a polymer-based paclitaxel-eluting stent in patients with diabetes mellitus: the LIPSIA Yukon trial.
    Desch S; Schloma D; Möbius-Winkler S; Erbs S; Gielen S; Linke A; Yu J; Lauer B; Kleinertz K; Dänschel W; Schuler G; Thiele H
    JACC Cardiovasc Interv; 2011 Apr; 4(4):452-9. PubMed ID: 21511226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative assessment of mammalian target of rapamycin inhibitor-eluting stents in the treatment of coronary artery bifurcation lesions: the CASTOR-Bifurcation registry.
    Sgueglia GA; Burzotta F; Trani C; Todaro D; Talarico GP; Niccoli G; Porto I; Leone AM; Coluccia V; Mazzari MA; Mongiardo R; Schiavoni G; Crea F
    Catheter Cardiovasc Interv; 2011 Mar; 77(4):503-9. PubMed ID: 20602477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiographic outcomes with biodegradable polymer and permanent polymer drug-eluting stents.
    Kufner S; Massberg S; Dommasch M; Byrne RA; Tiroch K; Ranftl S; Fusaro M; Schömig A; Kastrati A; Mehilli J;
    Catheter Cardiovasc Interv; 2011 Aug; 78(2):161-6. PubMed ID: 21400652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Instant stent-accentuated 3-dimensional optical coherence tomography of a bifurcation lesion treated with reverse minimum overlapping culotte stenting.
    Nakao F
    JACC Cardiovasc Interv; 2014 Sep; 7(9):e121-2. PubMed ID: 25129671
    [No Abstract]   [Full Text] [Related]  

  • 15. Treating the left main bifurcation lesion: the "three stent solution".
    Uretsky BF
    Catheter Cardiovasc Interv; 2009 Jan; 73(1):42-3. PubMed ID: 19089935
    [No Abstract]   [Full Text] [Related]  

  • 16. Stent strut fracture: seeing is believing.
    Carter AJ
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):619-20. PubMed ID: 18360854
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of in vivo acute stent recoil between the bioabsorbable everolimus-eluting coronary stent and the everolimus-eluting cobalt chromium coronary stent: insights from the ABSORB and SPIRIT trials.
    Tanimoto S; Serruys PW; Thuesen L; Dudek D; de Bruyne B; Chevalier B; Ormiston JA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):515-23. PubMed ID: 17503509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stentablation of an underexpanded stent in a heavily calcified lesion using rotational atherectomy.
    Lee S; Park KW; Kim HS
    J Cardiovasc Med (Hagerstown); 2012 Apr; 13(4):284-8. PubMed ID: 20489653
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymeric stents: degradable but strong.
    Lemos PA
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):524. PubMed ID: 17896407
    [No Abstract]   [Full Text] [Related]  

  • 20. Silent very late thrombotic occlusion of sirolimus-eluting stent confirmed by directional coronary atherectomy.
    Nakayama T; Kobayashi Y; Takano H; Kuroda N; Hiroshima K; Komuro I
    Circ J; 2009 Sep; 73(9):1762-4. PubMed ID: 19145041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.